Screen4 Limited Announces launch of Covid-19 Antibody Test, this is in response to the need for a managed and clear Return to Work Strategy.
“This back to lab blood test provides the most accurate type of test to measure the levels of potential antibodies following infection by the COVID-19 Virus” said David Grouse, Director at Screen4 Limited Announces launch of Covid-19 Antibody Test.
Benefits to users:
This test will allow individuals to clearly understand the level of antibodies within their system – post infection of the COVID-19 virus.
“This Test is complementary to our existing PCR swab test, as used in the NHS, to provide a full picture of infection and post infection,” said David Grouse, Director, Screen4 Limited “we are working with clients across the Construction, Aviation, financial services, Transport and petrochemical industries to implement a managed Return to Work Strategy based on known risks and clear information.
The challenges faced by companies at this time is unprecedented, they need to get their staff back to work in a safe and controlled way and to do that they need clear information about their staff and the level of risk posed by returning to the workplace for possible infection by the COVID-19 virus”
This test is based on the proven ELISA Platform and tests for two different Antibodies – IgA and IgG, this dual approach gives a high accuracy level of detection and provides actual levels of any relevant antibodies present.
Sensitivity = 100%*
Specificity = 98.5%*
*Based on most recent study data – being updated continually as new quantities of positive antibody samples are analysed.
The test is CE marked for use across the European union and the analysis is carried out in a German based laboratory which is accredited to
Current turnaround time is 2 days from receipt at the laboratory
The test is being deployed via Occupational Health Companies and direct to clinicians in the market sectors highlighted.
Further information is available at https://screen4.org/covid-19-antibody-testing/